Trial Profile
Safety, tolerability, pharmacokinetic and pharmacodynamic profiles of edoxaban in healthy post-menopausal or surgically sterile females, and healthy elderly males
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Sep 2011
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary)
- Indications Embolism; Stroke; Venous thromboembolism
- Focus Pharmacokinetics
- Sponsors Daiichi Sankyo Company
- 13 Sep 2011 Planned number of patients changed from 24 to NULL.
- 13 Sep 2011 New trial record